NEW YORK, Oct. 13, 2016 -- Progyny, a leading digital healthcare company, today announced Karin Ajmani, president of healthcare services at Progyny, will present the abstract titled, “Employer Engagement and Education Increases Access to Care and eSET Utilization,” at the American Society for Reproductive (ASRM) Medicine 2016 Scientific Congress in Salt Lake City. The presentation will showcase results from companies that launched Progyny’s fertility benefits plan in January 2016. The abstract will be presented on Monday, October 17, 2016 at 11:15AM MT.
The presentation will highlight the significance of educating employers on best practices for assisted reproductive technology (ART) and clinical outcomes by providing a comprehensive benefit without restrictions on treatments or a defined dollar maximum. By providing employers with a Progyny SMART™ (Science and Member-driven Advanced Reproductive Technology) Cycle treatment plan which includes embryo assessment tools and promotion of elective Single Embryo Transfer (eSET), the company has been able to increase access to fertility care, increase pregnancy rates, and decrease multiples (twins or more) to four percent from a national average of 28 percent.
“Our goal is to eliminate the $1 billion annual healthcare costs related to high-risk maternity care, pre-term birth and NICU that stem from IVF multiples,” said Ajmani. “By giving employees access to the best technologies and utilization of eSET, we’re able to reduce the rate of twins and multiples which then reduces the overall maternity costs for the employer.”
“We are thrilled to present these results and the talented physicians in our network deserve a tremendous amount of recognition for this achievement as well,” added Gina Bartasi, CEO of Progyny. “Their partnership and leadership towards shifting the industry to single embryo transfer has been instrumental to our success.”
For more information about Progyny or to learn more the SMART cycle, visit booth #1009 at ASRM or visit www.progyny.com.
About Progyny:
Progyny is a leading digital healthcare company combining data, science and technology to provide the first end-to-end, proactive fertility solution for both large, self-insured employers and today’s informed consumer. Progyny’s SMART™ Cycle plan design comprises best-in-class research and clinical solutions, including its proprietary Eeva™ technology, to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco and Menlo Park, CA. Please visit www.progyny.com.
Media Contact: Selena Yang [email protected] Phone: 646-768-9719


Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Italy Fines Apple €98.6 Million Over App Store Dominance
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 



